4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-390510
Chief Medical Officer sold 10,028 shares at an average $32.40 ($324,868)
From the SEC's structured data for this filing
Trades in this filing
Bedrosian Camille L · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-10 | Sale : show line 1 in the form | −7,947 | $32.21 | $256,004 | 280,145 | D |
| 2026-09-10 | Sale : show line 2 in the form | −2,081 | $33.09 | $68,864 | 278,064 | D |
| Open-market sales · 10,028 sh · avg $32.40 · $324,868 | ||||||
Loading xslF345X06/ownership.xml…